Literature DB >> 28131236

Regional volumetric change in Parkinson's disease with cognitive decline.

Myrlene Gee1, Juergen Dukart2, Bogdan Draganski3, W R Wayne Martin4, Derek Emery5, Richard Camicioli6.   

Abstract

BACKGROUND: Parkinson's disease (PD), characterized by motor dysfunction and cognitive decline, may demonstrate specific patterns of brain atrophy. Although cross-sectional magnetic resonance imaging (MRI) studies show correlation between regional brain volume loss and cognitive impairment, there is only scarce evidence from longitudinal studies validating the link between cognition and brain anatomy in PD.
OBJECTIVE: To test the relationship between magnitude and spatial extent of atrophy in PD patients with progressive, significant cognitive decline and dementia (PDD).
METHODS: We followed thirty-three initially non-demented patients with prevalent PD for three years while monitoring cognitive function and brain atrophy. Longitudinally acquired T1-weighted magnetic resonance images were analyzed in the voxel-based morphometry framework of SPM.
RESULTS: Groups did not differ significantly with respect to age or gender. More males developed PDD (7 males, 3 females) compared to those remaining intact (12 males, 11 females). Clusters of lower grey matter volume were found in PDD compared to PD in left uncus at baseline and an expanded region that included the left hippocampus and parahippocampal gyrus at 36months. The cognitive status by scan interaction showed differential changes between groups in the right insula. At a more liberal statistical threshold we observed changes in the right insula and bilateral hippocampi as well as the right cuneus additional to the lower brain stem.
CONCLUSIONS: Region specific atrophy, consistent with the pattern of cortical Lewy body deposition seen in autopsy studies, can be detected with MRI in PD patients with significant cognitive decline. MRI may be useful for tracking cognitive decline in PD.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive decline; Dementia; Magnetic resonance imaging; Parkinson's disease; Statistical parametric mapping

Mesh:

Substances:

Year:  2016        PMID: 28131236     DOI: 10.1016/j.jns.2016.12.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Searching for behavior relating to grey matter volume in a-priori defined right dorsal premotor regions: Lessons learned.

Authors:  Sarah Genon; Tobias Wensing; Andrew Reid; Felix Hoffstaedter; Svenja Caspers; Christian Grefkes; Thomas Nickl-Jockschat; Simon B Eickhoff
Journal:  Neuroimage       Date:  2017-05-25       Impact factor: 6.556

2.  Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson's disease mild cognitive impairment.

Authors:  Frederic Sampedro; Juan Marín-Lahoz; Ignacio Aracil-Bolaños; Andrea Horta-Barba; Saül Martínez-Horta; José María Gónzalez-de-Echávarri; Jesús Pérez-Pérez; Helena Bejr-Kasem; Berta Pascual-Sedano; Mariángeles Botí; Antonia Campolongo; Cristina Izquierdo; Alexandre Gironell; Beatriz Gómez-Ansón; Jaime Kulisevsky; Javier Pagonabarraga
Journal:  Brain Imaging Behav       Date:  2021-09-22       Impact factor: 3.978

Review 3.  Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Authors:  Jing Yang; Roxana G Burciu; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

4.  Altered emotional recognition and expression in patients with Parkinson's disease.

Authors:  Yazhou Jin; Zhiqi Mao; Zhipei Ling; Xin Xu; Zhiyuan Zhang; Xinguang Yu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-27       Impact factor: 2.570

Review 5.  Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).

Authors:  Paul Tuite
Journal:  Brain Sci       Date:  2017-06-16

Review 6.  Can neuroimaging predict dementia in Parkinson's disease?

Authors:  Juliette H Lanskey; Peter McColgan; Anette E Schrag; Julio Acosta-Cabronero; Geraint Rees; Huw R Morris; Rimona S Weil
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

7.  Neuroimaging in Parkinson's disease dementia: connecting the dots.

Authors:  Rimona S Weil; Joey K Hsu; Ryan R Darby; Louis Soussand; Michael D Fox
Journal:  Brain Commun       Date:  2019-07-08

8.  Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease.

Authors:  Rong Li; Ting Zou; Xuyang Wang; Hongyu Wang; Xiaofei Hu; Fangfang Xie; Li Meng; Huafu Chen
Journal:  Hum Brain Mapp       Date:  2021-11-18       Impact factor: 5.038

9.  Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.

Authors:  Mahsa Dadar; Myrlene Gee; Ashfaq Shuaib; Simon Duchesne; Richard Camicioli
Journal:  Neuroimage Clin       Date:  2020-07-17       Impact factor: 4.881

10.  Progressive brain atrophy and clinical evolution in Parkinson's disease.

Authors:  Massimo Filippi; Elisabetta Sarasso; Noemi Piramide; Tanja Stojkovic; Iva Stankovic; Silvia Basaia; Andrea Fontana; Aleksandra Tomic; Vladana Markovic; Elka Stefanova; Vladimir S Kostic; Federica Agosta
Journal:  Neuroimage Clin       Date:  2020-08-07       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.